Abstract Coronavirus disease of 2019 (COVID-19) has emerged as a global health threat.
Unfortunately, there are very limited approved drugs available with established efficacy …

The COVID-19 pandemic has caused a global health crisis, with no specific antiviral to treat
the infection and the absence of a suitable vaccine to prevent it. While some individuals …

SARS-CoV-2 emerged in late 2019 and resulted in the ongoing COVID-19 pandemic.
Several animal models have been rapidly developed that recapitulate the asymptomatic to …

Objectives To describe the clinical characteristics, laboratory results, imaging findings, and
in-hospital outcomes of COVID-19 patients admitted to Brazilian hospitals. Methods A cohort …

Abstract Coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), is associated with a high mortality rate …

Abstract Coronavirus disease 2019 (COVID-19) is a globally communicable public health
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) …

In December 2019, the world was introduced to a new betacoronavirus, referred to as
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) for its propensity to cause …

Abstract Background Coronavirus disease 2019 (COVID-19) is suspected to mainly be more
deleterious in patients with underlying cardiovascular diseases (CVD). There is a strong …

Mucus is an integral part of the respiratory physiology. It protects the respiratory tract by
acting as a physical barrier against inhaled particles and microbes. Excessive inflammation …

Rationale Factors associated with long-term sequelae emerging after the acute phase of
COVID-19 (so called “long COVID”) are unclear. Here, we aimed to identify risk factors for …